Grantham, Mayo, Van Otterloo & Co (GMO)
SBRA icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Sabra Healthcare REIT SBRA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-35,400
Closed -$853K – 623
2017
Q2 		$853K Buy
35,400
+19,700
+125% +$501K ﹤0.01% 380
2017
Q1 		$439K Buy
+15,700
New +$412K ﹤0.01% 408

Other funds holding SBRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SBRA Position: Q3 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Sabra Healthcare REIT (SBRA) in Q3 2017, closing a stake of 35,400 shares — an estimated $853K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SBRA in Q1 2017 and held it in 2 quarters. The position peaked at $853K in Q2 2017. 337 funds tracked by Wall St. Rank hold SBRA as of Q3 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Sabra Healthcare REIT position as of Q3 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 35,400 Sabra Healthcare REIT shares in Q3 2017, an estimated $853K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Sabra Healthcare REIT in Q1 2017 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Sabra Healthcare REIT position peaked at $853K in Q2 2017.
  • 337 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2017, filed 14 Nov 2017.